Dr. Manuel Marina Breysse
Talk
Artificial Intelligence in Cardiology: Expanding the Diagnostic Potential of the ECG
Biography
Dr. Manuel Marina Breysse is a scientist, AI researcher and cardiologist. He is the co-founder and CEO of Idoven, an AI deep tech company focused on advancing early detection and precision medicine for cardiovascular diseases by creating an AI-cardiologist expert in ECGs called Willem. Idoven has been recognized by TIME Magazine as one of the World’s Top HealthTech Companies (2025) and by CB Insights as one of the top 50 global companies in Digital Health (2023).
As a scientist he has conducted basic and translational research at the National Center for Cardiovascular Research (CNIC) in Spain. As co-founder and CEO at Idoven, Manuel Marina has led R&D, product development, and commercialisation of new AI medical measurement tools, as well as the design of clinical studies and data collection pipelines with hundreds of thousands of patients.
Dr. Marina Breysse specialized in arrhythmias and high-performance sports cardiology. He has served as a cardiologist of professional athletes at the Spanish Agency for Health Protection in Sports (AEPSAD). He is also a member of the European Society of Cardiology, an Associate Partner of the Spanish Society of Cardiology, and scientist at the Cardiovascular Disease Network Biomedical Research Center (CIBERCV).
Dr. Manuel Marina holds a degree in Medicine and Surgery from the University of Alcalá, a Master’s Degree in Statistics from the University of Córdoba, and Business Management and Leadership education from Harvard University, Singularity University, and Esade. Together with his co-authors he has published more than 30 scientific papers, more than 20 book chapters, and over 150 presentations and posters at international conferences. He has been granted research excellence: 3× European Seal of Excellence, 2× ERC grants, EIC Accelerator recipient, and 3× EIT Health grants, among other recognitions.